ArticlePloS one2014

Antitumor effect of the tyrosine kinase inhibitor nilotinib on gastrointestinal stromal tumor (GIST) and imatinib-resistant GIST cells.

Hiroyuki Sako et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.